Quote:
Originally Posted by Knight Hospitaller
It would be nice to stabilize "big pharma's" presence here. There was an article on Philly.com yesterday about a declining presence in the region.
|
I have a few friends who are cancer scientists and they had previously told me that Glaxo had started moving some of their staff scientists to the Research Triangle from Philadelphia who shared their (my friends') specialty, and that their feeling was that it would continue.
In an interesting turn of events, though...I saw some of them recently and they said that Glaxo was moving the very same scientists back. The feeling is there is a lot of related work happening at Penn and related institutions nearby and the pipeline (including my friend who is finishing up his PhD now) do not want to be in NC.
Hopefully others come to the same conclusion. Just the fact that this urban-suburban tug-of-war is even at the forefront of the decision makers in terms of attracting talent is nothing but positive for Philadelphia. Fact is...young educated people don't want to be in the middle of a suburban office park. It's nice that the C-Suite is finally listening...even if they are doing so reluctantly.